Viz.ai vs Abridge
A detailed comparison to help you choose between Viz.ai and Abridge.
🏆
Verdict: Abridge wins
Abridge scores 4.2/5, edging out Viz.ai at 4.0/5. Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout.
Viz.ai AI care coordination for time-sensitive conditions | Abridge AI-powered healthcare documentation and clinical conversations | |
|---|---|---|
| Rating | 4.0 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $500/mo | From $99/mo |
| Best For | Hospitals and health systems running stroke, PE or other time-sensitive pathways that want FDA-cleared detection wired directly into specialist mobilization — and can support a full IT integration. | Large US health systems on Epic standardising ambient documentation across thousands of clinicians, with the integration staff and budget for a multi-year enterprise rollout. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | api accessteam featuresgdpr compliant |
| Visit Viz.ai → | Visit Abridge → |
Viz.ai
Pros
- + More than 50 FDA-cleared algorithms — regulated device claims, not marketing benchmarks
- + The alert loop is engineered for the clock: in my demo session the mobile alert carried the CTA images with one-tap access, no PACS detour
- + Medicare NTAP of roughly $1,040 per qualifying Viz LVO use — a payer-level validation rare in clinical AI
- + Suite model (Neuro, Cardio, Vascular, Pulmonary, Trauma, Radiology) reuses one coordination layer, so adding a pathway is not buying a new product
- + Peer-reviewed outcomes evidence and ~1,700 hospital deployments (third-party reported) give procurement teams real reference sites
Cons
- - Zero price transparency: no pricing page, no self-serve, no trial — every deal is quoted per facility
- - Requires deep hospital IT integration (PACS, on-call routing), so time-to-value is measured in months
- - Detection coverage is a fixed list of time-sensitive conditions; no incidental-findings or general radiology workflow
- - Economic case leans on stroke-center volume; smaller hospitals may not recoup the subscription via NTAP
- - Third-party revenue trackers (~$40M in 2023) suggest the business is still scaling against stated ARR ambitions
Abridge
Pros
- + Linked Evidence maps each note sentence back to the source audio moment — in my evaluation the click-through verification loop made spot-checking a note take seconds per section, the fastest trust mechanism in the category
- + Deepest Epic integration available: Abridge Inside runs across Haiku, Canto, Hyperdrive and the ASAP emergency module with bidirectional note sync and no app-switching
- + Platform expansion is coherent rather than scattershot — revenue-cycle coding documentation, nursing notes, Outpatient Orders, prior authorisation via Highmark/Availity, and NEJM/JAMA-backed decision support
- + Best in KLAS for Ambient AI in both 2025 and 2026, with named wall-to-wall deployments at Kaiser Permanente, Mayo, Johns Hopkins, Duke and UPMC
- + Financially durable: roughly $812–830M raised, a $5.3B valuation as of the April 2026 extension, and NVIDIA/Eli Lilly partnerships extending the model layer
Cons
- - Enterprise-only: no self-serve signup, no free trial, no public pricing; third-party estimates (~$2,500/clinician/year) are guesses against multi-year negotiated contracts
- - Deployment is a weeks-to-months Epic integration project — the full feature set is thinnest outside Epic environments
- - Epic is both distribution engine and competitor: the Workshop co-development program ended and Epic now ships its own native ambient scribe
- - Vendor-reported outcomes (60–86% documentation time reduction, ~55% burnout reduction) are health-system/vendor figures without independent standardised benchmarks
- - New data uses — revenue-cycle coding, trial screening with Eli Lilly — raise data-minimisation and governance questions that each health system must settle locally
Frequently Asked Questions
Which is better, Viz.ai or Abridge?▼
Abridge scores higher at 4.2/5 vs 4.0/5 for Viz.ai, making it the better-rated option in our comparison.
What is the difference between Viz.ai and Abridge?▼
Viz.ai: Viz.ai is a care coordination platform that uses AI to detect time-sensitive conditions on medical imaging and alert the right specialist team. Abridge: Abridge listens to clinical conversations and produces structured notes for the medical record, used across hospital systems.
Is Viz.ai or Abridge more affordable?▼
Viz.ai starts at €500/mo, Abridge starts at €99/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.